Today's guest is Jesse Johnson, Head of Data Science and Data Engineering at Dewpoint Therapeutics in Boston, MA. Founded in 2018, Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery.

Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates, including cancer, neurodegeneration, infectious disease and metabolic disease. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into treatments for the toughest diseases.

In the episode, Jesse will discuss:

The interesting work they are doing in Biotechnology,

The main objectives and goals of their work within Drug Discovery,

Combining his life sciences skills with technical skills,

An insight into the data science & engineering team,

What’s in store for the near future at Dewpoint, &

His advice to those considering a career in life sciences